Editorial: Evaluating the Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinemia

被引：1
|
作者：
Bhardwaj, Nakul J. [1 ]
Kim, Rebecca G. [1 ]
机构：
[1] Univ Utah Hlth, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Salt Lake City, UT 84132 USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2025年 / 61卷 / 04期
关键词：
D O I：
10.1111/apt.18453
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：727 / 728
页数：2
相关论文
共 50 条
  • [41] Hepatic steatosis contributes to cognitive impairment in patients with metabolic dysfunction-associated steatotic liver disease and/or type 2 diabetes-mellitus
    del Campo, Nuria Perez Diaz
    Ferro, Arianna
    Castelnuovo, Gabriele
    Caviglia, Gian Paolo
    Rosso, Chiara
    Guariglia, Marta
    Dileo, Eleonora
    Armandi, Angelo
    Saba, Francesca
    Saracco, Giorgio Maria
    Barutta, Federica
    Beccuti, Guglielmo
    Gruden, Gabriella
    Bugianesi, Elisabetta
    JOURNAL OF HEPATOLOGY, 2024, 80 : S483 - S483
  • [42] Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa
    Younossi, Zobair M.
    Golabi, Pegah
    Paik, James
    Owrangi, Soroor
    Yilmaz, Yusuf
    El-Kassas, Mohamed
    Alswat, Khalid
    Alqahtani, Saleh A.
    LIVER INTERNATIONAL, 2024, 44 (04) : 1061 - 1070
  • [43] Exploring the Prevalence and Coexistence of Metabolic Dysfunction-associated Steatotic Liver Disease in Type 2 Diabetes Mellitus Patients Using Ultrasound: A Cross-sectional Study
    Hadadi, Ibrahim
    Adam, Mohamed
    Musa, Mustafa J.
    Gareeballah, Awadia
    Alqahtani, Mansour
    Kanbayti, Ibrahem
    Hazazi, Ahmed
    CURRENT MEDICAL IMAGING, 2025,
  • [44] Visceral Fat and Diabetes: Associations With Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Kumar, Ashish
    Arora, Anil
    Sharma, Praveen
    Jan, Shayesta
    Ara, Ishrat
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2025, 15 (01)
  • [45] Association between the peripheral neutrophil-to-lymphocyte ratio and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes
    Zhu, Nan
    Song, Yongfeng
    Zhang, Chen
    Wang, Kai
    Han, Junming
    FRONTIERS IN MEDICINE, 2023, 10
  • [46] Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study
    Gosnell, Joseph Matthew
    Golovko, George
    Arroyave, Esteban
    Moghe, Akshata
    Kueht, Michael L.
    Saldarriaga, Omar Abdul
    Mckinney, Kevin H.
    Stevenson, Heather L.
    Ferguson, Monique R.
    WORLD JOURNAL OF DIABETES, 2024, 15 (05)
  • [47] Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Polyzos, Stergios A.
    Targher, Giovanni
    CURRENT OBESITY REPORTS, 2024, 13 (02) : 242 - 255
  • [48] The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients
    Paklar, Natasa
    Mijic, Maja
    Filipec-Kanizaj, Tajana
    BIOMEDICINES, 2023, 11 (11)
  • [49] New Insights on Using Oral Semaglutide versus Dapagliflozin in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Stratina, Ermina
    Stanciu, Carol
    Nastasa, Robert
    Zenovia, Sebastian
    Stafie, Remus
    Rotaru, Adrian
    Cuciureanu, Tudor
    Muzica, Cristina
    Sfarti, Catalin
    Girleanu, Irina
    Minea, Horia
    Petrea, Oana
    Huiban, Laura
    Chiriac, Stefan
    Singeap, Ana-Maria
    Vlad, Oana
    Cojocariu, Camelia
    Trifan, Anca
    DIAGNOSTICS, 2024, 14 (14)
  • [50] Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease
    Mellemkjaer, Anders
    Kjaer, Mikkel Breinholt
    Haldrup, David
    Gronbaek, Henning
    Thomsen, Karen Louise
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 28 - 34
12345